(Reuters) - Regeneron Pharmaceuticals Inc said the U.S. Food and Drug Administration has approved the expanded use of its eye drug Eylea for the treatment of diabetic macular edema. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/HJxo4hlM-7o/story01.htm
Read More
No comments:
Post a Comment